<DOC>
	<DOCNO>NCT03079557</DOCNO>
	<brief_summary>This pilot test feasibility 'REpurposing BOtulinum Toxin Treatment Obesity Adolescents ' trial ( ReBOO-trial ) . The full-scale ReBOO investigate safety efficacy intragastric injection botulinum toxin A antrum area stomach . These injection repeat every six month . The study sample adolescent obesity respond standard conservative treatment .</brief_summary>
	<brief_title>Feasibility Pilot ReBOO-trial</brief_title>
	<detailed_description />
	<mesh_term>Obesity</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>1 . Written ( sign ) inform consent 2 . Age gender adjust body mass index ( ISOBMI ) â‰¥ 35 ISOBMI &gt; 30 comorbidities include hypertension , nonalcoholic fatty liver disease , hyperlipidemia impair glucose tolerance 3 . Having partaken comprehensive multidisciplinary lifestyle treatment obesity duration 12 month , without achieve clinically significant weight loss ( nonresponder ) 1 . Known hypersensitivity excipients investigational medicine product ( IMP ) 2 . Neuromuscular disorder 3 . History dysphagia 4 . History aspiration tendency aspiration pneumonia 5 . Known lung disease continuous treatment 6 . Congenital acquire heart disease 7 . Previous experience side effect Botulinum toxin type A 8 . Present gastric disease dysfunction 9 . Previous bariatric surgery 10 . History cancer 11 . Serious binge eat disorder 12 . Untreated hypothyroidism 13 . Use aminoglycoside antibiotic spectinomycin week prior injection , medicinal product interfere neuromuscular transmission ( neuromuscular block agent ) 14 . Medication know affect appetite 15 . Syndromic obesity 16 . Mentally immature degree doubt subject 's ability assent 17 . Issues relate language culture may complicate trial participation 18 . Pregnancy breastfeed</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Adolescent</keyword>
	<keyword>Injections , intraperitoneal</keyword>
	<keyword>Endoscopy</keyword>
	<keyword>Botulinum Toxins , Type A</keyword>
	<keyword>OnabotulinumtoxinA</keyword>
</DOC>